BeStock  
Stocks › Biotechnology › IMVT

Immunovant IMVT

US equityMarket cap rank #1778Biotechnology
$31.77 −$0.75 (-2.31%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $31.51 -0.82%
Open$32.26
Prev close$32.52
Day range$31.61 – $32.77
Volume704.9K
Market cap$6.57B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership113.3%+4.38 pts vs. prior quarter
Institutions holding274+5 vs. prior quarter
Insider trades (recent)17 buys / 33 sellsNet selling
Short interest8.98% of floatDays to cover 15.3 · as of 30 Oct 2026
Short-sale volume share20.2%5-day average of daily volume

Short-sale volume as % of daily volume

13%20%28%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$7.64M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$1.7MSuper−$6.0MBig−$2.9MMid+$1.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 73.2% of shares outstanding.

Largest holders

  • Roivant Sciences Ltd.54.76%
  • FMR7.58%
  • Deep Track Capital, LP4.51%
  • BlackRock3.59%
  • Farallon Capital Management, L.L.C.2.81%
  • Morgan Stanley2.75%
  • State Street Global Advisors2.24%
  • Morgan Stanley Investment Management Inc.2.75%

By investor type

  • Public Company58.87%
  • Mutual Fund30.32%
  • Hedge Fund15.23%
  • VC/PE Fund7.43%
  • Private Company1.05%
  • Individual/Insider0.71%
  • Insurance Company0.21%
  • Government Pension Fund0.16%

Reported short interest has risen from 8.22% to 8.98% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Two Seas Capital LP Hedge Fund 2026/Q3 +1,464,187 2.2%
Morgan Stanley Public Company 2026/Q3 +1,150,007 2.7%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,150,007 2.7%
Fisher Investments Mutual Fund 2026/Q3 +545,730 0.3%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +448,555 2.0%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +354,234 2.1%
BNY Mellon Asset Management Mutual Fund 2026/Q3 +349,330 0.3%
UBS Asset Management Mutual Fund 2026/Q3 +270,768 0.4%
BlackRock Mutual Fund 2026/Q3 +244,874 3.6%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +167,725 0.1%
Group One Trading LLC Private Company 2026/Q3 +162,839 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +323,352 0.2%
Farallon Capital Management, L.L.C. Hedge Fund 2026/Q3 +4,259,000 2.8%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +1,240,654 0.6%
BlackRock Mutual Fund 2026/Q3 +606,400 3.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Nov 2026 Atul Pande Independent Director Derivative Exercise and Sale -3,000 $36.00 110,328
27 Oct 2026 Tiago Girao Chief Financial Officer Open Market Disposition -6,606 $28.50 38,981
20 Oct 2026 Jay Stout Chief Technology Officer Open Market Disposition -2,595 $28.94 51,270
6 Oct 2026 Christopher Van Tuyl Chief Legal Officer Open Market Disposition -1,327 $32.06 40,283
6 Oct 2026 Melanie Gloria Chief Operating Officer Open Market Disposition -2,241 $32.06 23,926
6 Oct 2026 Jay Stout Chief Technology Officer Open Market Disposition -3,809 $32.06 47,615
1 Oct 2026 Eric Venker Chief Executive Officer Derivative Exercise and Sale -89,392 $34.11 24,823
30 Sep 2026 Eric Venker Chief Executive Officer Derivative Exercise and Retained +2,795 $14.46 24,823
22 Sep 2026 Christopher Van Tuyl Chief Legal Officer Open Market Disposition -2,846 $36.36 38,436
27 Aug 2026 Atul Pande Independent Director Derivative Exercise and Sale -1,500 $43.27 110,328
19 Aug 2026 Melanie Gloria Chief Operating Officer Open Market Disposition -3,056 $44.16 21,405
23 Jul 2026 Atul Pande Independent Director Derivative Exercise and Sale -1,500 $39.80 110,328
22 Jul 2026 Tiago Girao Chief Financial Officer Open Market Disposition -6,798 $38.69 32,563
22 Jul 2026 Jay Stout Chief Technology Officer Open Market Disposition -2,857 $38.69 43,227
7 Jul 2026 Christopher Van Tuyl Chief Legal Officer Open Market Disposition -1,206 $39.99 34,409
7 Jul 2026 Melanie Gloria Chief Operating Officer Open Market Disposition -2,036 $39.99 17,589
7 Jul 2026 Jay Stout Chief Technology Officer Open Market Disposition -3,487 $39.99 39,834
1 Jul 2026 Eric Venker Chief Executive Officer Derivative Exercise and Sale -89,721 $38.48 22,028
30 Jun 2026 Eric Venker Chief Executive Officer Derivative Exercise and Retained +2,467 $14.46 22,028
25 Jun 2026 Atul Pande Independent Director Derivative Exercise and Sale -1,500 $38.01 40,100

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 18,550,107 9.0% 15.3
15 Oct 2026 18,273,675 8.8% 12.4
30 Sep 2026 17,416,613 8.4% 9.6
15 Sep 2026 17,253,948 8.4% 14.3
31 Aug 2026 15,784,450 7.6% 14.1
14 Aug 2026 16,981,939 8.2% 15.1

Discussion

No comments yet — be the first to weigh in on IMVT.

Sign in to join the discussion.

Scroll to Top